| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 3 | |
| #2 | United States | 2 | |
| #3 | African Regional Industrial Property Organization | 1 | |
| #4 | Australia | 1 | |
| #5 | Brazil | 1 | |
| #6 | Israel | 1 | |
| #7 | Republic of Korea | 1 | |
| #8 | New Zealand | 1 | |
| #9 | WIPO (World Intellectual Property Organization) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Organic fine chemistry | |
| #2 | Pharmaceuticals |
| # | Technology | |
|---|---|---|
| #1 | Heterocyclic compounds | |
| #2 | Therapeutic chemical compounds | |
| #3 | Medical preparations |
| # | Name | Total Patents |
|---|---|---|
| #1 | Bauer Leonhardt | 9 |
| #2 | Frobel Klaus | 9 |
| #3 | Adorjan Immanuel | 9 |
| #4 | Fuernsinn Clemens | 5 |
| #5 | Furnsinn Clemens | 2 |
| #6 | Adjoran Immanuel | 2 |
| #7 | Froble Klaus | 1 |
| #8 | Fürnsinn Clemens | 1 |
| #9 | Fursinn Clemens | 1 |
| Publication | Filing date | Title |
|---|---|---|
| EP2315766A1 | Octahydroquinolizines for antidiabetic treatment | |
| EP2266967A1 | Intermediates for the preparation of octahydroquinolizines | |
| US2011003808A1 | Octahydroquinolizines for antidiabetic treatment | |
| EP2072515A1 | Substituted quinazolidines for antidiabetic treatment |